InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Krasner Alan Seth, Directeur Médical. Officer active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 5 disclosures have been logged. Activity tracked since 19 January 2022. The latest transaction was filed on 17 October 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Krasner Alan Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
7,000 shares@ US$12.0132.0% of flowCommon StockSEC:0001209191-23-053186:0
1,687 shares@ US$17.1211.0% of flowCommon StockSEC:0001209191-23-019770:0
19,500 shares0Common StockSEC:0001209191-23-015598:0
14,250 shares0Common StockSEC:0001209191-22-015129:0
6,700 shares@ US$12.0139.9% of flowCommon StockSEC:0001209191-22-004453:0
5 of 5 declarations
About Krasner Alan Seth
Alan Seth Krasner is the Chief Medical Officer at Crinetics Pharmaceuticals, Inc. He is responsible for medical leadership and product development strategies. His role is essential in ensuring that Crinetics' products meet safety and efficacy standards.
